Clinical trial

Intravitreal Ranibizumab (Lucentis®) for Neovascular Glaucoma- a Randomized Controlled Study

NCT02914626

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2016-10-01

PhasePHASE3

Study timeline

Study start (unknown)2016-10-01Date precision: month

Registry last updated2016-09-27

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Glaucoma, Neovascularunresolved

Ranibizumabunresolved

Interventions

Intravitreal ranibizumabDRUG

Sponsors & collaborators

LEANDRO CABRAL ZACHARIASlead sponsor

Novartiscollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02914626 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.